Complement factor D in age-related macular degeneration - Wikidata - awgldk - TriplyDB

Complement factor D in age-related macular degeneration

Complement factor D in age-related macular degeneration

http://www.wikidata.org/entity/Q35593260

about

Inflammation and its role in age-related macular degeneration Inhibiting Alternative Pathway Complement Activation by Targeting the Factor D Exosite Fit for the Eye: Aptamers in Ocular Disorders Genome-wide association studies: getting to pathogenesis, the role of inflammation/complement in age-related macular degeneration The effect of lutein supplementation on blood plasma levels of complement factor D, C5a and C3d.Potential role of lampalizumab for treatment of geographic atrophy.Age-Related Macular Degeneration: A Disease of Systemic or Local Complement Dysregulation?Plasma levels of complement proteins from the alternative pathway in patients with age-related macular degeneration are independent of Complement Factor H Tyr⁴⁰²His polymorphism.Applying complement therapeutics to rare diseases.Mouse genetics and proteomic analyses demonstrate a critical role for complement in a model of DHRD/ML, an inherited macular degeneration.Drugs in Phase II clinical trials for the treatment of age-related macular degeneration.Complement Activation and Inhibition in Retinal Diseases.Genetic Determination of Serum Levels of Diabetes-Associated Adipokines Risk factors and biomarkers of age-related macular degeneration.THE PATHOPHYSIOLOGY OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION AND THE COMPLEMENT PATHWAY AS A THERAPEUTIC TARGET.The impact of the human genome project on complex disease Inhibitors of factor d may provide a treatment for age-related macular degeneration.Exploring the cross talk between ER stress and inflammation in age-related macular degeneration.Correlation of neutrophil/lymphocyte and platelet/lymphocyte ratio with visual acuity and macular thickness in age-related macular degeneration.Advances in Age-related Macular Degeneration Understanding and Therapy.Modern Therapeutic Approaches for Noninfectious Ocular Diseases Involving Inflammation.Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration.The eye as a complement dysregulation hotspot.Exploring the Use of Molecular Biomarkers for Precision Medicine in Age-Related Macular Degeneration.A Controlled Release System for Long-Acting Intravitreal Delivery of Small Molecules

P2860

Q26768520-40EE4EDE-81EB-4D0E-A06E-156D37BDC745 Q27677455-CE4D3B12-F697-46F7-865D-BBF85914D195 Q28828283-82CA03A5-048E-4123-9DA1-F7F76EECCEA1 Q34930448-D4FB5AC6-7FE0-403A-B7B0-574F205FC5EA Q34979785-3239BC06-C403-447C-A3A3-F7BBB1173587 Q35746909-93689B22-7CF8-49B6-AA44-FE8B986DD9DD Q35750545-F9385783-D24E-47D5-AEB5-70B4EF955A98 Q36218190-3604BDF1-80C6-4299-9728-E851602F3A7B Q36315497-7868F8A1-9A45-4EEA-A378-E06C79608744 Q37380159-D7B2A8CF-6518-4127-B721-7E4D4CFE551B Q38253067-9AE2B6DE-8FDA-45AF-B9FF-3070D65349D0 Q38616354-6A62E00E-3C50-4521-A68C-D8E4450DAB91 Q38727331-AD507573-23DF-40BC-9368-717BD4B7EA92 Q38828895-D81BBECA-DC5D-490F-B7A4-D3BF88E17BB1 Q39024579-B4AEF4AA-D6F9-4911-9E29-2D7274B6AFFA Q39158595-CCBD9DC0-05E1-47FC-AB90-5F8352705FA4 Q39787177-DAE847E3-CBE1-45B2-8BA0-2E55C2A0866C Q41105949-4E7743B2-BFDF-4536-A9FD-55CD02FB6FBD Q42256425-D8F82C68-6CA8-4EC8-B085-ABB442EE9BD9 Q47427948-E647CD23-1CCF-4080-B72A-695D0A7DC613 Q47442388-2E546C96-D69A-46CF-A153-05F27E3F1BFC Q48240873-55967879-56A0-4223-9455-4C0EEF0AE5D1 Q48290530-E62C5451-492A-44F4-8A8F-BBB5950A6863 Q52559837-9501D621-9CDA-4DF0-A19B-4FEFA80B5F7E Q58699181-4743C326-4CDE-432E-AC8D-3714A4983CC6

P2860

Complement factor D in age-related macular degeneration

http://www.wikidata.org/entity/Q35593260

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Complement factor D in age-related macular degeneration

@ast

Complement factor D in age-related macular degeneration

@en

type

label

Complement factor D in age-related macular degeneration

@ast

Complement factor D in age-related macular degeneration

@en

prefLabel

Complement factor D in age-related macular degeneration

@ast

Complement factor D in age-related macular degeneration

@en

P1433

Q35593260-3B501995-BEE7-4E70-877A-6FBCE19375AB

P1476

Q35593260-B3DA9C68-021A-4050-B4A3-A6C0739E81E4

P2093

Q35593260-0200C578-C2C3-4921-809B-A0AF08100BEE

Q35593260-08E05B44-8C64-4668-A390-25BFB6C931C2

Q35593260-14DCD398-56FB-42CE-9DB2-C70F58880164

Q35593260-15071556-1F53-49FF-8AF3-DC635D5ABED6

Q35593260-294D7594-AD5C-4F02-96D8-8A440FCE0AF3

Q35593260-41B01853-2F22-4A34-BDD3-ED5791FFA6F0

Q35593260-54B85CD6-A550-4188-A3F0-95EE6B6AA2CF

Q35593260-54BF5F33-0E71-49E9-967D-F13DFCBE0827

Q35593260-704D645F-9084-4D7C-9400-D690624AFCE4

Q35593260-78FCF4B9-7356-4933-AE5D-D25DD242D1A6

P2860

Q35593260-019796E6-F219-4FDF-826D-C03A3FE81994

Q35593260-0A88BEEB-E536-40FC-B705-B4DAA8849A02

Q35593260-14053874-3AD4-41C8-9591-4AC05A4399AC

Q35593260-16B3B8B7-B00B-4E46-A84A-2D89BCAF595F

Q35593260-18097C6A-9F83-411D-ACC2-044C632B058B

Q35593260-27FBF418-3EB5-484B-99CF-D7A8DD742740

Q35593260-33C1C6DE-5931-4BFA-BFB2-4A9A3805B015

Q35593260-385DFB30-C828-4794-8F8F-0AD8F75DEA5E

Q35593260-45694422-7B53-42A8-8CCD-5F316844EBC1

Q35593260-4D661848-9012-40B0-B044-98E3AAE4D418

P304

Q35593260-528042F1-1EC8-4D1B-8C27-29777C4F8F47

P31

Q35593260-74ea8045-1563-4dd2-8c55-2fa0c1759ba7

Q35593260-DD9B1182-42BE-4699-91D1-8828DCB3B4A8

P356

Q35593260-2955CEB3-B7E7-468C-9089-796BD75A4C23

P407

Q35593260-557DE0CD-69F6-4996-8AE6-5E5B88B50F04

P433

Q35593260-016F16A8-DF54-4C0F-B3C1-D9AABF537B83

P478

Q35593260-A9A6548B-D76F-464E-B51D-8C608CE50B74

P50

Q35593260-4545F304-D421-465D-A096-03FCA20FE70E

Q35593260-7788F02C-B011-4AF1-9F17-6A186EF75466

Q35593260-8847179B-5EA9-4B03-A301-9502D461E78B

Q35593260-E34C206A-0DCD-443D-81A2-A5AFE25033FE

Q35593260-F285FC10-792C-4D1A-A5AD-231F4DC8DCD8

P577

Q35593260-3A73E4DB-B08D-44B3-B04F-E57701FF8914

P5875

Q35593260-1C6B05EA-9515-496E-AFDC-771577E8C5CE

P698

Q35593260-2613064C-0DD3-4A1C-8AB5-0B185C108179

P932

Q35593260-A097AC8D-6F3B-4F21-AF51-2C99497BD14D

P356

P1433

Investigative Ophthalmology & Visual Science

P1476

Complement factor D in age-related macular degeneration

@en

P2093

Alan F Wright

http://www.w3.org/2001/XMLSchema#string

Anneke I den Hollander

http://www.w3.org/2001/XMLSchema#string

Anthony T Moore

http://www.w3.org/2001/XMLSchema#string

Baljean Dhillon

http://www.w3.org/2001/XMLSchema#string

Carel Hoyng

http://www.w3.org/2001/XMLSchema#string

Chloe M Stanton

http://www.w3.org/2001/XMLSchema#string

Elod Kortvely

http://www.w3.org/2001/XMLSchema#string

Johanna M Seddon

http://www.w3.org/2001/XMLSchema#string

John R W Yates

http://www.w3.org/2001/XMLSchema#string

Kanda Atsuhiro

http://www.w3.org/2001/XMLSchema#string

P2860

Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue

Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration

Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC)

Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes

Complement factor D, a novel serine protease

Structural basis of profactor D activation: from a highly flexible zymogen to a novel self-inhibited serine protease, complement factor D

Complement. First of two parts

Systemic complement activation in age-related macular degeneration

Mechanism of action of factor D of the alternative complement pathway

Risk factors for age-related macular degeneration.

P304

8828-8834

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1167/IOVS.11-7933

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P50

Caroline Hayward

Dwight Stambolian

Mohammad Othman

P577

2011-11-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51720070

http://www.w3.org/2001/XMLSchema#string

P698

22003108

http://www.w3.org/2001/XMLSchema#string

P932

3230905

http://www.w3.org/2001/XMLSchema#string